Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Introduction: The optimal timing for Hartmann's reversal remains a topic of ongoing debate. This study aimed to assess postoperative outcomes in patients undergoing early versus late Hartmann's reversal at a tertiary academic center in Germany.

Methods: A single-center retrospective cohort study was conducted, including all patients who underwent Hartmann's reversal between January 2008 and July 2020. Patients were stratified into early (ER) and late (LR) reversal groups using a median cut-off value of 159 days. Operative outcomes including major morbidity and overall postoperative complications were compared between both groups. Factors associated with major postoperative morbidity were detected using uni- and multivariate regression models.

Results: A total of 133 patients classified into the ER (n = 67, 50.38%) and LR (n = 66, 49.62%) groups were analyzed. There were no significant differences in overall morbidity (ER 56.72% versus LR 39.39%, p = 0.057) and major morbidity rates (Clavien-Dindo ≥ IIIa) (ER 28.36% versus LR 21.21%, p = 0.423) between both groups. On multivariate analysis, smoking (p = 0.006), chronic renal disease (p = 0.003) and anastomotic configuration (p = 0.003) were identified as significant factors contributing to major morbidity after Hartmann's reversal.

Conclusion: Hartmann's reversal is still associated with an increased risk of postoperative complications. However, timing of Hartmann's reversal does not seem to influence postoperative morbidity. Of note, patient-related modifiable factors as well as the anastomotic configuration are important determinants of major complication occurrence.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12221653PMC
http://dx.doi.org/10.1016/j.sipas.2025.100292DOI Listing

Publication Analysis

Top Keywords

hartmann's reversal
20
major morbidity
12
timing hartmann's
8
postoperative complications
8
postoperative morbidity
8
anastomotic configuration
8
reversal
7
hartmann's
6
morbidity
6
postoperative
5

Similar Publications

Laparoscopic Management of Grade C Anastomotic Leak following Left-Sided Colorectal Resection.

JSLS

September 2025

Colorectal and Minimally Invasive Surgery Specialists, Jackson Medical Group, Jackson S. Medical Center, Miami, Florida, USA. (Drs. Altamirano, Adogowa, and Lujan).

Background: Management of left-sided colorectal Grade C anastomotic leak (AL) has traditionally been managed via laparotomy. However, with the growing adoption of minimally invasive techniques, recent literature suggests that laparoscopic surgery provides a safe and viable alternative for managing Grade C leaks.

Methods: This study is a case series that consists of 7 adults that underwent laparoscopic reintervention of purulent or feculent peritonitis from left-sided colorectal AL during the period of 2016-2024 at our institution.

View Article and Find Full Text PDF

SARS-CoV-2 Remdesivir Exposure Leads to Different Evolutionary Pathways That Converge in Moderate Levels of Drug Resistance.

Viruses

July 2025

Copenhagen Hepatitis C Program (CO-HEP), Department of Infectious Diseases, Copenhagen University Hospital, 2650 Hvidovre and Department of Immunology and Microbiology, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Various SARS-CoV-2 remdesivir resistance-associated substitutions (RAS) have been reported, but a comprehensive comparison of their resistance levels is lacking. We identified novel RAS and performed head-to-head comparisons with known RAS in Vero E6 cells. A remdesivir escape polyclonal virus exhibited a 3.

View Article and Find Full Text PDF

Alcohol-use disorder and alcohol-associated liver disease (ALD) are major causes of death and liver transplantation. The gut-liver axis has a crucial yet poorly understood role in ALD pathogenesis, which depends on microbial translocation. Intestinal goblet cells (GCs) educate the immune system by forming GC-associated antigen passages (GAPs) on activation of muscarinic acetylcholine receptor M4 (mAChR4, also known as M), enabling sampling of luminal antigens by lamina propria antigen-presenting cells.

View Article and Find Full Text PDF

In this paper, we present what we believe to be a novel method based on the coaxial reverse Hartmann principle for the online measurement and calibration of large-size flat tempered glass surface shapes. By embedding a pinhole-ring light source component at the center of a dot matrix pattern light source and employing a movable flat standard sample, we achieve rapid calibration of the optical axis and the mapping relationship between the spot centroid coordinates on detector surface and the incident angles of light. This coaxial reverse Hartmann optical path features no loss of light energy, a direct coaxial configuration, and no light obstruction, which minimizes the incident angle of light compared to off-axis optical paths, thereby reducing the influence of surface vibration on measurement accuracy.

View Article and Find Full Text PDF

From dealer to doctor: A case study examining how Purdue Pharma sought to leverage racial health disparities to attenuate flagging OxyContin sales.

Soc Sci Med

May 2025

The Pennsylvania State University Department of Geography, United States; The Pennsylvania State University Scales of Corporate Harm Lab, United States; The Pennsylvania State University Consortium on Substance Use & Addiction, Social Science Research Institute, United States. Electronic address: lm

The objective of this study is to demonstrate ways in which Purdue Pharma and their primary consultant, McKinsey & Company, sought to leverage existing health disparities to maintain profits as the opioid epidemic worsened and regulatory pressure and negative media attention led to decreases in prescriptions of OxyContin and similar drugs. We use documents from the UCSF-Johns Hopkins Opioid Industry Documents Library, and correspondent media and policy documents, to evaluate "Project Tango," a strategy the two companies devised between 2014 and 2015 to enter the substance use disorder treatment market and expand sales to new customers. We find that Project Tango was one part of a broader strategy by Purdue Pharma to adapt and profit from the existing landscape of structural racism in medical care by investing more in drug sales and targeting medically underserved patients, particularly Black and Latino populations, and those enrolled in Medicaid.

View Article and Find Full Text PDF